A Mutation Determining the Loss of HLA-A2 Antigen Expression in a Cervical Carcinoma Reveals Novel Splicing of Human MHC Class I Classical Transcripts in Both Tumoral and Normal Cells
Overview
Genetics
Affiliations
MHC heterogeneity and response of metastases to immunotherapy.
Algarra I, Garrido F, Garcia-Lora A Cancer Metastasis Rev. 2021; 40(2):501-517.
PMID: 33860434 DOI: 10.1007/s10555-021-09964-4.
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer.
Stokidis S, Fortis S, Kogionou P, Anagnostou T, Perez S, Baxevanis C Cancers (Basel). 2020; 12(6).
PMID: 32570992 PMC: 7352811. DOI: 10.3390/cancers12061623.
MHC Class I Regulation: The Origin Perspective.
Sznarkowska A, Mikac S, Pilch M Cancers (Basel). 2020; 12(5).
PMID: 32375397 PMC: 7281430. DOI: 10.3390/cancers12051155.
Cancer immune escape: MHC expression in primary tumours versus metastases.
Garrido F, Aptsiauri N Immunology. 2019; 158(4):255-266.
PMID: 31509607 PMC: 6856929. DOI: 10.1111/imm.13114.
Rejection versus escape: the tumor MHC dilemma.
Garrido F, Ruiz-Cabello F, Aptsiauri N Cancer Immunol Immunother. 2017; 66(2):259-271.
PMID: 28040849 PMC: 11028748. DOI: 10.1007/s00262-016-1947-x.